chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The patient called today and reported that yesterday her arm started itching in the area where she got her vaccine.  She can't stop scratching and has put multiple creams on it and has also taken Benadryl.  It is now red.
A few minutes after receiving the vaccine the patient passed out and her father carried her back to the pharmacy. The father stated that she fell forward, and he picked her up. She was conscious when he picked her up and brought her back to the pharmacy.
Injection site pain x 3 days, itchiness at injection site beginning 1/17/21 x 5 days, swelling at injection site x 3 days, redness at injection site diameter four inches ongoing, ring around the outer edge of redness with raised skin, feels similar to scar tissue ongoing since 1/25/21
Pentacel administered instead of Vaxelis. Patient had to return to office later in day on 5/19/23 to receive HepB (Energix-B) vaccination.
improperly stored product administered; No additional AE reported; This spontaneous report was received from a physician  and refers to a patient of unknown age and gender. Information regarding the patient's concomitant therapies, concurrent conditions, medical history and historical drugs was not provided.  On 17-NOV-2020,  the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live rHA (recombinant Human albumin) (PROQUAD) Lot # T025506, expiration date 23-JAN-2022, 0.5 milliliter for prophylaxis (route of administration not reported).     The improperly stored dose of the suspect vaccine experienced a temperature excursion of 22.8 degree fahrenheit (°F) for 13 hours and 25 minutes with a previous temperature excursion of 17.4 °F for 31 minutes and 30 seconds.  The call was made due to a digital data logger. No adverse symptoms were reported.
extreme & persistent nausea/vomiting/diarrhea with food intolerance/aversion resulting in 58 lb weightloss
Patient received a dose of Pfizer COVID-19 Vaccine formulation (5-11yr) that may have been reconstituted with a single use vial of 0.9% NS that was entered into multiple times to reconstitute other vials of Pfizer vaccine. Staff did not realize the 10mL vial was for single use only (to take out 1.3mL then discard). Each time the vial was used it was swabbed with alcohol and a new syringe was used to enter the vial then to add the diluent to the Pfizer vaccine for reconstitution. The 10mL, 0.9% NS vial was disposed of at the end of each day. The patient did not experience any adverse reaction. At the recommendation of Pfizer and the CDC, due to lack of stability data, it was advised to revaccinate the patient.
I use O2 when sleeping.   on 2/6/21 at 5 PM was having a slight headache and body aches. went to sleep for 1.5 hours.  at 7 PM Took my blood pressure was at 156/ 72 with bpm 82.  I took 1/2 pills of VALSARTAN  80MG and METROPROLOL TART   50MG 7:45 PM  blood pressure reading 132/67  bpm 79  2/7/21    4 AM blood pressure 129/63 bpm 59  7:30 AM took all my medication had breakfast 8:45 AM blood pressure 122/58  bpm 63
Lower back pain; Swollen lymph nodes in left armpit which kept her up all night; Fatigue; low grade fever for 3 days; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Lower back pain), LYMPHADENOPATHY (Swollen lymph nodes in left armpit which kept her up all night), FATIGUE (Fatigue) and PYREXIA (low grade fever for 3 days) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 069F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BACK PAIN (Lower back pain), LYMPHADENOPATHY (Swollen lymph nodes in left armpit which kept her up all night), FATIGUE (Fatigue) and PYREXIA (low grade fever for 3 days). At the time of the report, BACK PAIN (Lower back pain), LYMPHADENOPATHY (Swollen lymph nodes in left armpit which kept her up all night) and FATIGUE (Fatigue) outcome was unknown and PYREXIA (low grade fever for 3 days) had resolved.      No concomitant product use was provided. No treatment medication was provided.   This case was linked to MOD-2022-562865, MOD-2022-563381 (Patient Link).
pt recvd 3 doses of Engerix-B vax & did not seroconvert; booster doses were administered;
(02/13/2021) Both Leg motor failure (weak legs, maybe fatigue) and syncope, treated with saline for dehydration. (08/07/2021) Unusually harsh coughing and sneezing, nasal stuffiness, and was advised to drink fluids.
Fever for 3 days of about 100, vomiting and diarrhea for two weeks. Vomiting continued for 18 days.
? Immediate reaction: Mild soreness and itching ? Delayed Reaction:  o Approximately 4 ? 6 hours after vaccination ? Symptoms: Itching, swelling, and redness of the injection site (The swelling was in an oval shape, probably about as long as a kiwi and half as tall) ? Measures taken:  I took two Benadryl and applied Triamcinolone Acetonide Cream  o Approximately 12 ? 15 hours after vaccination ? Symptoms: Continued itching, still swollen, though slightly smaller o For the next 3 ? 5 days ? Swelling persisted. Applied Triamcinolone Acetonide Cream twice daily. ? Took 50 mg Benadryl for 2 more nights. ? Skipped allergy shots for the week ? Currently: Mild itching, and swelling has reduced to the approximate size of a silver dollar. Injection site is only slightly red.  o Still applying Triamcinolone Acetonide Cream.
Headache  General symptoms: chills, fever, headaches, joint pains, muscle pains, fatigue.  Narrative:
Itchy at injection site with red circular area about 3 inches in diameter. First noticed on 2/22/21, 9 days after receiving the vaccine.
Information has been received from a physician concerning a 20 year old male who on 26-NOV-1990 was vaccinated with the first dose of MMR II, on 14-OCT-1994 was vaccinated with the second dose of MMR II.  On 01-DEC-2009 the patient experienced mumps.  Diagnose on 4-DEC-2009 revealed the patient had parotitis on both sides and the patient was afebrile.  Laboratory tests on 4-DEC-2009 included serum IgM <1:10, serum IgG 5.68 and serum amylase 322.  Follow-up information was received which reported that on 06-JAN-2010 the patient experienced mumps.  Diagnose on 8-JAN-2010 revealed the patient had parotitis on both sides.  Laboratory tests on 08-JAN-2010 included serum IgM 1.55, serum IgG 4.53 and serum amylase 338.  Additional information has been requested.
feeling crappy; my muscles hurt; This is a spontaneous report from a contactable Other Health Professional (patient) via the Pfizer sponsored program. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on 20Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had the vaccine in the morning of 20Jan2021 and she was feeling crappy and her muscles hurt in Jan2021. She stated that she read if you have Covid you should take TYLENOL instead of Ibuprofen. She was wondering if this was the same with the vaccine or if it was okay to take ibuprofen. The outcome of the events feeling crappy and my muscles hurt was unknown.  Information on the lot/batch number has been requested.
On 11/29/2022, Patient received an influenza vaccine. The vaccine was received at pharmacy. Approximately 0800 hours on 11/30/2022, Patient started to experience upper respiratory issues, along with constant coughing. On 12/04/2022, Patient attended drill. During the first part of the morning, patient began experiencing slight dizziness/light-headedness. As the day progressed, patient became dizzier and lightheaded. Patient described the symptom as the equivalent of being intoxicated and began running a slight fever.
Body aches, chills, very tired, slight fever all occured the following day (Sunday 4/11/21 and the morning on Monday 4/12/21).  I was back to normal Monday afternoon and have felt fine since.
This spontaneous report was received from a healthcare worker concerning an adult patient of unknown age and gender. Information on pertinent medical history, drug reactions/allergies and concomitant medications was not reported. On unknown date, the patient was inadvertently vaccinated with a pediatric dose of VAQTA for prophylaxis. No adverse effects were reported. No product quality complaint (PQC) was involved.
5 minutes after receiving 1t dose of Covid-19 vaccine, the patient passed out and fell from his chair. He looked clammy and pale, but regained consciousness in a few seconds. He still felt very faint and shaky, and asked for some gatorade. We had him lie on his back and elevate his feet until he felt better. EMS arrived and checked on him and he felt good enough to walk out on his own accord.
MMRV administered to left thigh on 4/4/23. Mother reported pain, erythema, and edema surrounding injection site on 4/5/23. On 4/6/23, mother brought patient to office d/t development of vesicles at site and erythema spreading across his left thigh.   Photos taken and uploaded into chart. Erythema with vesicles noted about 3 cm in diameter out from injection site. Mild, scattered erythema noted to anterior left thigh and lateral left thigh. No warmth noted to area. No significant edema noted.   Reassured mother that likely a local reaction d/t the MMRV vaccine, but assured that I would submit documentation regarding potential adverse reaction.
This spontaneous report as received from a Pharmacy Doctor referred to a 78 years old female patient with drug reactions/allergy to niacin, LESCOL and SOMA. The patient was administered the pneumococcal vaccine (manufacturer unspecified) several years ago. The patient was vaccinated SQ with a dose of ZOSTAVAX (lot number 0168AE, site and dose not reported) on 26-JUN-2012. No other co-suspects were reported. Concomitant medications included TDAP. On 02-JUL-2012, 7 days after onset of therapy, the patient experienced itching, pain and a darkened rash-like area around the injection site. The patient called the reporting pharmacist for medical attention. The pharmacist recommended hydrocortisone cream to be used as a treatment for the adverse event. At the time of the report, the outcome of the events was not recovered/not resolved. The relatedness for the events was unknown for ZOSTAVAX. Additional information has been requested.
I do not have vaccine information other than Moderna. Pt is a CPS teacher and I saw her for the sudden hearing loss.
pt recv vax; 15mar96 exp 4-5 lesions at inject site; no further details provided;
I tested positive for COVID-19 on May 20th. My oxygen levels were going below 90. Because my doctor was worried about me because I have asthma  she gave me Paxovid. I also had a sinus infection.
Patient became pale and dizzy after receiving menveo and HPV vaccines in office.  He vomited x 1, did not lose consciousness He was assisted to the floor with his legs elevated.  VS obtained  - HR reassuring, breathing easily BP was low however he came in with the same BP and was to have it measured again before leaving clininc. Blood glucose was normal.  Tdap vaccine was deferred Episode lasted about 15 minutes in total. Color returned to face and patient stated that he felt better. Was observed sitting up in chair for 10 minutes prior to walking out of clinic with his mom  Tx consisted of repositioning, placing cool compress on head, sips of apple juice, reassurance
pt recvd vax 6OCT93; 11OCT93 noticed a knot @ the inject site; MD described the react an an urticarial-like lesion;
pt recvd vax; inc t & fussiness 2-12 hrs p/ vax;by next am t 103.5,legs & foot were swollen & very sensitive; wheezy cough, very lethargic;had apap q 4-5 hrs prior & p/; started dph next day;
Severe itching of hands, then hives and itching on arms, legs, areas with friction like clothing seams, tight clothing, pressure again skin. Dermatagraphia was a problem. Treated with anti-histamines. Symptoms calmed down and then worsened 8 days after the second dose of the vaccine, exactly like the first dose. Continued anti-histamines for about a month.   Itching and hives flare up at times and go away. I take an anti-histamine 2-3x a month to control these flare ups.   I had absolutely no problem of this kind before the vaccination.   Tinnitus also developed during this time and continues.
Moderate to Severe joint pain; High temperature of 103.0; Moderate chills and shaking; Moderate chills and shaking; Severe fatigue; sore eyes and eye brows; moderate to severe headache; loss of apetite; moderate to severe swelling on upper back of neck with prominent lumps on both sides; moderate to severe swelling on upper back of neck with prominent lumps on both sides; This is a spontaneous report from a contactable consumer (patient, self-reporting). A 81-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number and expiration dates were not reported), via an unspecified route of administration in arm left on Feb2021 at 10:45 as dose 1, single and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number and expiration dates were not reported), via an unspecified route of administration in arm left on Feb2021 at 10:45 as dose 2, single for COVID-19 immunisation. Medical history was none. Concomitant medications included ibuprofen and daily vitamins. The patient previously took feldene and experienced drug hypersensitivity. Patient did not receive other vaccine in four weeks. Patient did not have COVID prior vaccination. Patient was not tested for COVID tested post vaccination. The patient experienced moderate to severe joint pain, moderate to severe swelling on upper back of neck with prominent lumps on both sides, high temperature of 103.0, moderate chills and shaking, severe fatigue, sore eyes and eye brows and moderate to severe headache and loss of appetite. The patient underwent lab tests and procedures which included body temperature: high temperature of 103. Therapeutic measures were not taken as a result of the events. The outcome of the event was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
COVID-19 symptoms started on 06/27/2022; tested positive on 06/30/2022. Symptoms were general malaise, headache, cough, and shortness of breath. My voice left me around the 1st or 2nd and returned on August 1. I had the other symptoms for 2 weeks and the 3rd week I returned to work and I felt better but very weak and not having a voice was somewhat of a disadvantage. 08/02/22 my voice returned and that same week I began to feel a lot better and my energy returned. I was still having lung issues like shortness of breath and I was coughing the entire time with any type of exertion like showering or walking to the kitchen. Every once in awhile I will cough and feel it in my lungs and I wonder what kind of long term effects I'll have. I did call a physician on call and they prescribed Paxlovid for 5 days and it didn't seem like it helped me very much.
Document Type: History and Physical Document Subject: History & Physical Note Performed By:  MD on April 21, 2022 00:14 EDT Verified By:  MD on April 21, 2022 00:14 EDT Encounter Info: 000920321825,  Inpatient, 04/20/22 - 05/23/22 * Final Report * History of Present Illness/Subjective  This is a 63-year-old male who uses with known underlying liver cirrhosis who presents on 4-20-2022 brought in to  emergency department with a chief complaint of abdominal pain and bilateral lower extremity edema with associated shortness of breath. He is being admitted for acute liver failure with meld of greater than 50% in the setting of acute alcoholic hepatitis and renal failure and impending withdrawal. Transplant was attempted however  are either on diversion or have a waiting list. So he is being admitted here in the meantime.  In the ER he is 130/80 on room air. Hemoglobin 12.1 from 13.5. INR 2.06 previously 1.04 back in January. Sodium 131, potassium 3.0, chloride 90, gap of 19 with a CO2 of 22, creatinine is 1.86 from 0.87. Alk phos is 145 from 50 and ALT is 166 from 35. Pending CT scan of the abdomen and pelvis without contrast.  Is unable to provide me any history. He is definitely encephalopathic. His wife is present at bedside and provides some history stating that he is a heavy drinker with last drink being the evening of 4-19-2022. She is known that something has been wrong with his liver for quite some time, I believe she said that he is only has had cirrhosis for multiple years now. Review of Systems  Unable to obtain as patient is encephalopathic.
pain left arm; throat closing; aches of entire body, "hit by a truck"; hard to breathe; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 65-year-old male patient who received Herpes zoster (Shingrix) (batch number G2J53, expiry date 17th April 2023) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of overdose (1st dose received on 24th September 2021, refer case US2021AMR248492).   On 29th November 2021, the patient received Shingrix (intramuscular) .5 ml. On 30th November 2021, 1 days after receiving Shingrix, the patient experienced pain in arm, throat constriction, general body pain and difficulty breathing. The patient was treated with ibuprofen and dronabinol (Thc). On 1st December 2021, the outcome of the general body pain was recovering/resolving. On an unknown date, the outcome of the pain in arm, throat constriction and difficulty breathing were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm, throat constriction, general body pain and difficulty breathing to be related to Shingrix.  Additional details were provided as follows: The patient self-reported this case. The patient received dose of Shingrix vaccine and experienced pain on the left arm (where he was vaccinated), aches and throat closing which started on 30th November 2021 and all were still ongoing.  The patient stated that his arm pain was a bit better today (day of reporting). The aches he was experiencing was of his entire body he felt like he got hit by a truck, it was better today (day of reporting). The patient lastly stated that he felt like his throat was closed and it was hard to breathe, this was still not yet resolved.  The patient took 400mg ibuprofen and 12.5mg THC to help with the pain and aches. The reporter did not consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR248492:Same patient, different dose
Patient got the vaccine and 10 days later got Covid; Patient got the vaccine and 10 days later got Covid; Sinus drainage; This is a spontaneous report from a Pfizer-sponsored program IBCC (Inbound Call Center for HCPs) from a contactable physician. This pharmacist reported similar events for two patients. This is the first of two reports for Infection Control Nurse.  A female patient of an unspecified age received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got the vaccine and 10 days later, got COVID. So, the patient got swabbed because of the sinus draining but she was not ill. The patient was not sick she got some sinus drainage. The outcome of event was unknown. The patients were wondering if they need to start over or if they were okay to get the second dose.  Information on the lot/batch number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with the suspected vaccine BNT162B2 in this patient cannot be completely excluded.  However, the duration of 10 days since the vaccine first dose is short, and it is unlikely patient would have fully developed immunity.  Further information like confirmative virus genome /nucleic acid detection needed for meaningful medical assessment.,Linked Report(s) : US-PFIZER INC-2021001212 same reporter/product, similar events, different patients.
Headache, Myalgia, Fever, NauseaVomiting, chills, pain and redness at site Narrative:  Other Relevant History:
AFTER RECEIVING THE FLU SHOT THE PATIENT STARTED HAVING RESPIRATORY DIFFICULTY AND A 1.5 X 2.0 ERUPTION APPEARED IN THE SITE OF INJECTION WITH ACCOMPANING RASH AND REDNESS.
This is my second COVID Pfizer vaccine dose. After both dosages, a couple of days later, I began "smelling" smells that weren't there. In my case, I was smelling "cigarette smoke" and "wood smoke" smells even though there were no cigarettes or wood burning in my vicinity. I had no health complications as a result, it was only slightly unpleasant at times. I did not seek treatment for this because it was a minor inconvenience and the issue went away after my first dose in a week. It hasn't been a week since my second dose but I assume it will go away similarly.
Started with a knot at the shot It became bigger and red and red and big as a golf ball.  Had fatigue anxiety weak chills fever palpations shortness of breath not able walk up stairs good muscle pain  hip pains arm pain going down to my finger tips was not able to hold up straight up still today hurt to pull back or raise it all the way up.